Interventional Neurology Market Updates by 2031
MARKET OVERVIEW
The interventional neurology devices help in the diagnosis, prevention, and treatment of a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. These devices are minimally invasive image-based technologies. The procedures involving these devices are used in the diagnosis and treatment of diseases of the head, neck, and spine. According to a worldwide WHO report, the prevalence of Alzheimer's and other forms of dementia was nearly 3 per 1000 in 2021. Moreover, the geriatric population is rising globally which is more prone to mental disorders.
MARKET SCOPE
The "Global Interventional Neurology Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Interventional Neurology market with detailed market segmentation by products, applications, and geography. The report provides key statistics on the market status of the leading Interventional Neurology market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers
Restraints
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Interventional Neurology market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Interventional Neurology market in these regions.
IMPACT OF COVID-19 ON INTERVENTIONAL NEUROLOGY MARKET
As a result of the COVID-19 pandemic many radiology departments have experienced a rapid decline in imaging case volumes. This has important implications on the short-term and long-term economic stability of neurological procedures across all healthcare practice settings. Due to lockdown imposed by the governments across the world many neurological procedures were delayed, and supply chain restriction has limited the availability of resources needed to deliver imaging services. Moreover, the COVID-19 pandemic has disrupted the spectrum of clinical research, including delaying diagnoses and therapeutics and in few cases halting clinical trials.
MARKET PLAYERS
The report covers key developments in the Interventional Neurology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Interventional Neurology market are anticipated to lucrative growth opportunities in the future with the rising demand for Interventional Neurology in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Interventional Neurology market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The interventional neurology devices help in the diagnosis, prevention, and treatment of a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. These devices are minimally invasive image-based technologies. The procedures involving these devices are used in the diagnosis and treatment of diseases of the head, neck, and spine. According to a worldwide WHO report, the prevalence of Alzheimer's and other forms of dementia was nearly 3 per 1000 in 2021. Moreover, the geriatric population is rising globally which is more prone to mental disorders.
MARKET SCOPE
The "Global Interventional Neurology Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Interventional Neurology market with detailed market segmentation by products, applications, and geography. The report provides key statistics on the market status of the leading Interventional Neurology market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on products, the global Interventional Neurology market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, neurothrombectomy devices.
- Based on application, the market is categorised into artery stenosis, ischemic strokes, brain aneurysm, vein stenosis, others.
MARKET DYNAMICS
Drivers
- Growing target patient population.
- Rise in demand for minimally invasive neurosurgical procedures.
- Favorable medical reimbursements for neurological procedures.
- Increase in research in the field of neurovascular therapies
Restraints
- High procedural cost of neurovascular surgeries and related products.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Interventional Neurology market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Interventional Neurology market in these regions.
IMPACT OF COVID-19 ON INTERVENTIONAL NEUROLOGY MARKET
As a result of the COVID-19 pandemic many radiology departments have experienced a rapid decline in imaging case volumes. This has important implications on the short-term and long-term economic stability of neurological procedures across all healthcare practice settings. Due to lockdown imposed by the governments across the world many neurological procedures were delayed, and supply chain restriction has limited the availability of resources needed to deliver imaging services. Moreover, the COVID-19 pandemic has disrupted the spectrum of clinical research, including delaying diagnoses and therapeutics and in few cases halting clinical trials.
Interventional Neurology Market Report Analysis
Interventional Neurology Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott Laboratories
- Johnson and Johnson
- Boston Scientific Corporation
- Stryker Corporation
- Medtronic PLC
- Terumo Corporation
- Penumbra Inc
- Microport Scientific Corporation
- Merit Medical Systems Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- Aneurysm Coiling and Embolization Devices
- Cerebral Balloon Angioplasty and Stenting Systems
- Support Devices
- Neurothrombectomy Devices
By Application
- Artery Stenosis
- Ischemic Strokes
- Brain Aneurysm
- Vein Stenosis
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the Interventional Neurology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Interventional Neurology market are anticipated to lucrative growth opportunities in the future with the rising demand for Interventional Neurology in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Interventional Neurology market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Johnson and Johnson
- Boston Scientific Corporation
- Stryker Corporation
- Medtronic PLC
- Terumo Corporation
- Penumbra, Inc.
- Microport Scientific Corporation
- Merit Medical Systems, Inc.
- W.L. Gore and Associates, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Interventional Neurology Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott Laboratories
2. Johnson and Johnson
3. Boston Scientific Corporation
4. Stryker Corporation
5. Medtronic PLC
6. Terumo Corporation
7. Penumbra, Inc.
8. Microport Scientific Corporation
9. Merit Medical Systems, Inc.
10. W.L. Gore and Associates, Inc.
1. Abbott Laboratories
2. Johnson and Johnson
3. Boston Scientific Corporation
4. Stryker Corporation
5. Medtronic PLC
6. Terumo Corporation
7. Penumbra, Inc.
8. Microport Scientific Corporation
9. Merit Medical Systems, Inc.
10. W.L. Gore and Associates, Inc.